Nerve growth factor gene therapy activation of neuronal responses in Alzheimer disease

JAMA Neurology

Volumn 72, Issue 10, 2015, Pages 1139-1147

  Tuszynski, Mark H ^a,b   Yang, Jennifer H ^a   Barba, David ^c   Hoi Sang, U ^c   Bakay, Roy A E ^d   Pay, Mary M ^a   Masliah, Eliezer ^a   Conner, James M ^a   Kobalka, Peter ^a,e   Roy, Subhojit ^a,e   Nagahara, Alan H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR; PROTEIN P75; TAU PROTEIN; NGF PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; CELL DEGENERATION; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO GENE TRANSFER; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE THERAPY; HUMAN; IN VIVO GENE TRANSFER; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NERVE SPROUTING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTHUMOUS CARE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCHWANN CELL; SIGNAL TRANSDUCTION; STEREOLOGY; SURVIVAL TIME; AUTOPSY; BRAIN; CLINICAL TRIAL; DRUG EFFECTS; GENE TRANSFER; GENETICS; METABOLISM; NERVE CELL; NERVE DEGENERATION;

AGED; ALZHEIMER DISEASE; AUTOPSY; BRAIN; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE GROWTH FACTOR; NEURONS;

EID: 84944076745     PISSN: 21686149     EISSN: 21686157     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.1807     Document Type: Article

References (36)

1. Nagahara AH, Merrill DA, Coppola G, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med. 2009;15(3):331-337.
2. Kordower JH, Winn SR, Liu YT, et al. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA. 1994;91(23):10898-10902.
3. Tuszynski MH, UHS, Amaral DG, Gage FH. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci. 1990;10(11):3604-3614.
4. Conner JM, Darracq MA, Roberts J, Tuszynski MH. Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation. Proc Natl Acad Sci USA. 2001;98(4):1941-1946.
5. Nagahara AH, Mateling M, Kovacs I, et al. Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice. J Neurosci. 2013;33(39):15596-15602.
6. Tuszynski MH, Thal L, Pay M, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005;11(5):551-555.
7. Goedert M, Fine A, Dawbarn D, Wilcock GK, Chao MV. Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. Brain Res Mol Brain Res. 1989;5(1):1-7.
8. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci. 1995;15(9):6213-6221.
9. Blurton-Jones M, Kitazawa M, Martinez-Coria H, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA. 2009;106(32):13594-13599.
10. Williams LR. Hypophagia is induced by intracerebroventricular administration of nerve growth factor. Exp Neurol. 1991;113(1):31-37.
11. Winkler J, Ramirez GA, Kuhn HG, et al. Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Ann Neurol. 1997;41(1):82-93.
12. Wenk GL. The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiol Learn Mem. 1997;67(2):85-95.
13. Mufson EJ, Ma SY, Dills J, et al. Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002;443(2):136-153.
14. Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. Reduction of cortical TrkA but not p75NTR protein in early-stage Alzheimer's disease. Ann Neurol. 2004;56(4):520-531.
15. Hadaczek P, Eberling JL, Pivirotto P, Bringas J, Forsayeth J, Bankiewicz KS. Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC. Mol Ther. 2010;18(8):1458-1461.
16. Rafii MS, Baumann TL, Bakay RA, et al. A phase 1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease. Alzheimers Dement. 2014;10(5):571-581.
17. Conner JM, Muir D, Varon S, Hagg T, Manthorpe M. The localization of nerve growth factor-like immunoreactivity in the adult rat basal forebrain and hippocampal formation. J Comp Neurol. 1992;319(3):454-462.
18. Conner JM, Varon S. Characterization of antibodies to nerve growth factor: assay-dependent variability in the cross-reactivity with other neurotrophins. J Neurosci Methods. 1996;65(1):93-99.
19. Mai JK, Assheuer J, Paxinos G. Atlas of the Human Brain. New York, NY: Elsevier Inc; 2003.
20. Chen KS, Gage FH. Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration. J Neurosci. 1995;15(4):2819-2825.
21. Tuszynski MH, Gage FH. Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery. Proc Natl Acad Sci USA. 1995;92:4621-4625.
22. Kordower JH, Herzog CD, Dass B, et al. Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys. Ann Neurol. 2006;60(6):706-715.
23. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10(3):381-391.
24. Tuszynski MH, Roberts J, Senut MC, UHS, Gage FH. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther. 1996;3(4):305-314.
25. Mandel RJ, Gage FH, Clevenger DG, Spratt SK, Snyder RO, Leff SE. Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration. Exp Neurol. 1999;155(1):59-64.
26. Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool. 1951;116(2):321-361.
27. Wong AW, Yeung JK, Payne SC, Keast JR, Osborne PB. Neurite outgrowth in normal and injured primary sensory neurons reveals different regulation by nerve growth factor (NGF) and artemin. Mol Cell Neurosci. 2015;65:125-134.
28. Smithson LJ, Krol KM, Kawaja MD. Neuronal degeneration associated with sympathosensory plexuses in the trigeminal ganglia of aged mice that overexpress nerve growth factor. Neurobiol Aging. 2014;35(12):2812-2821.
29. Killock D. Experimental arthritis: NGF promotes synovial nerve sprouting. Nat Rev Rheumatol. 2012;8(3):124.
30. Lin CL, Heron P, Hamann SR, Smith GM. Functional distinction between NGF-mediated plasticity and regeneration of nociceptive axons within the spinal cord. Neuroscience. 2014;272:76-87.
31. Holtzman DM, Li Y, Chen K, Gage FH, Epstein CJ, Mobley WC. Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration. Neurology. 1993;43(12):2668-2673.
32. Martínez-Serrano A, Fischer W, Björklund A. Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron. 1995;15(2):473-484.
33. Marks WJ Jr, Bartus RT, Siffert J, et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010;9(12):1164-1172.
34. Bankiewicz KS, Forsayeth J, Eberling JL, et al. Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol Ther. 2006;14(4):564-570.
35. Fischer W, Wictorin K, Björklund A, Williams LR, Varon S, Gage FH. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature. 1987;329(6134):65-68.
36. Markowska AL, Koliatsos VE, Breckler SJ, Price DL, Olton DS. Human nerve growth factor improves spatial memory in aged but not in young rats. J Neurosci. 1994;14(8):4815-4824.